In the IG primary yesterday, two issues were priced totaling US$2.8bn, lifting weekly IG issuance to US$15.90bn and September volume to US$135.70bn, according to IFR data. The average book order for ...

Kajeet and Avery Telehealth announced a strategic partnership. The FDA has approved Apple’s sleep apnea detection feature.

Warren Biddle hit the exit from his role as SVP, global head of commercial at Gilead’s CAR-T unit Kite Pharma to take on the ...

Ascendis Pharma A/S (ASND) said that it has priced its underwritten public offering of 2 million American Depositary Shares or 'ADSs' ...

Plus, news about GSK, Novo Nordisk, Tanai Therapeutics, Nomic Bio, Brenus Pharma, Xspray, Achilles Therapeutics, BioXcel Therapeutics and Nuvalent: Ascendis’ $300M offering: The Danish company ...

Ascendis Pharma A/S (ASND) said that it has commenced an underwritten public offering of $300 million of American Depositary Shares ...

A/S (Nasdaq: ASND) today announced that it has commenced an underwritten public offering of $300,000,000 of American ...

Ascendis Pharma (Nasdaq: ASND) has announced positive top-line data from the pivotal Phase II ApproaCH trial of TransCon CNP ...

Check the time stamp on this data. Updated AI-Generated Signals for Ascendis Pharma A/s (ASND) available here: ASND.

Ascendis' TransCon CNP showed similar efficacy to BioMarin's Voxzogo but offers once-weekly dosing. Learn more on BMRN and ...

The combination of belrestotug and dostarlimab significantly improved response rates in patients with previously untreated ...

BioMarin Pharmaceutical Inc.'s stagnant shares present a compelling investment opportunity amid uncertainty in the ...